1 / 14

Pharmacodynamics

59-291 Section 1, Lecture 7. Pharmacodynamics. Detailed mechanism of action by which drugs produce drug produce their biochemical and physiological effect Dose response relationship; relationship between drug concentration and magnitude of drug effect

mollie-burks
Download Presentation

Pharmacodynamics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 59-291 Section 1, Lecture 7 Pharmacodynamics • Detailed mechanism of action by which drugs produce drug produce their biochemical and physiological effect • Dose response relationship; relationship between drug concentration and magnitude of drug effect • Provides scientific basis for the selection and use of drugs to counteract specific pathophysiologic mechanisms in particular disease

  2. Nature of drug receptors • Drugs produce their effects by interacting of receptors • Most ligands bind to protein receptors, which are embedded in the membrane • Some agents act directly to on DNA or membrane lipids

  3. Table 3-1 Drug Receptors

  4. Types of drug receptors • G-protein coupled receptors (GPCR) • Guanine nucleotide binding protein (G protein) • Extracellular/transmembrane domain binds to ligand • Intracellular domain binds to effector molecules (G protein)

  5. Types of drug receptors • G-protein coupled receptors (GPCR) • Guanine nucleotide binding protein (G protein) • Enzymes • Competitive and noncompetitive inhibitors • Membrane transport proteins • Ligand and voltage-gated ion channels • Neurotransmitter transporters • Membrane lipids and phospholipids • Anesthetics and alcohol • Steroid hormone receptors • Intracellular proteins, translocate to nucleus

  6. A small # of drugs produce their physiological effect without interacting with receptors. Examples: Drugs that bind to enzymes interfere with the normal activity of the enzyme in one of 2 ways Competitive- Non-competitive- Drugs can also bind to membrane transport proteins (competitively and non-competitively) and inhibit their function. Some drugs can also bind to membrane lipids and DNA in order to produce their action.

  7. Drug receptor interactions are very specific. They form ionic, hydrophobic and H-bonds with their receptor. The receptor binding site recognizes the 3-D shape of their ligands. L-isoproterenol binds to a -adrenergic receptor with higher affinity than its mirror image D-isoproterenol.

  8. The non-covalent interactions are reversible as a result drugs dissociate from their receptors as their concentration in the plasma decreases. Affinity- is the tendency of a drug to combine with its receptor [D] + [R] [D-R] Effect Law of mass action: the # of R occupied by D depends on the [D] And the K D - theratio of drug receptor dissociation k2 and association k1 rate K D= k2/ k1 The lower theK D higher the affinity. This occurs if the association rate constantk1 >> (much greater than) k2 . k1 k2

  9. KD= the concentration of drug required to saturate 50% of the receptors Most effective drugs have KDs in the micromolar (10-6) to nanomolar (10-9) range. Signal transduction: the process where the binding of a drug to its receptor initiates a cascade of biochemical events that result in the physiological effect. Membrane receptors are coupled to with a G-protein, an ion channel or an enzyme For example G proteins:

  10. Gas = Stimulatory; increase adenylate cyclase (AC) activity Gai = Inhibitory ; decrease AC activity Gaq= activate phospholipase C >> formation of Inositol triphosphate (IP3) and diacylglycerol from (DAG) from membrane phospholipids

  11. Efficacy or Intrinsic activity- the ability of a drug to initiate a cellular effect Agonist- drug has both receptor affinity and intrinsic activity Antagonist- drug has receptor affinity only.

  12. 3 Types of Agonists Full- max physiological response Partial- sub maximal physiological response In the presence of a full agonist a partial agonist behaves like an antagonist. Inverse agonist- decreases the rate of signal transduction Antagonists bind to receptor binding-site and prevent the action of agonists and inverse agonists.

  13. Practice Questions • Which of the following drug is more effective if they are administered with the same dose? Why? • Drug A with KD = 3x10-10 • Drug B with KD = 2x10-5 • Drug A, because it has a lower KD

  14. How does a Gaq increase IP3? How does IP3 function in the cells • Activates phospholipase C • IP3 releases calcium from intracellular storage sites and augment calcium-induced processes such as muscle contraction

More Related